Literature DB >> 8501397

Granulocyte activation induced by intense interval running.

A B Gray1, R D Telford, M Collins, M S Baker, M J Weidemann.   

Abstract

Activation of granulocytes has been associated with normal immune function, inflammation, and exercise-induced muscle damage. The effect of intense interval running on granulocyte activation was examined by use of flow cytometry, monoclonal antibodies, and spectrophotometric techniques. Eight trained males [maximal oxygen uptake VO2max, mean (SD) = 64.4 (3.6) ml/kg/min; age 30.1 (4.8) years] undertook an intense interval exercise (treadmill running) protocol to exhaustion. Subjects completed an average of 16.5 one-minute runs. Granulocyte expression of CR3 (CD11b), receptor for complement component C3bi (6 and 24 h post-test), and Fc gamma RIII (CD16) (24 h post-test) and the plasma concentration of elastase-inhibitor complex (1 h post-test) increased significantly (all P < .05). Subjects (8 of 8) exhibited a post-test decrease at either 1 or 6 h (P < .01) and a 24-h post-test significant increase (7 of 8; P < .05) in granulocyte 90 degrees light scattering (LS). Plasma lactoferrin (Lf) concentration, although increased by 17% at 6 h post-test, was not significantly different from resting values at any sampling point. Changes in plasma Lf and median channel 90 degrees LS were significantly correlated (r = -.43, P = .04), raising the possibility of monitoring exercise-induced granulocyte activation (degranulation) by flow cytometry. Intense interval exercise appears to induce granulocyte activation, as manifested by release of granule proteins and changes in 90 degrees LS and expression of both Fc and complement receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8501397     DOI: 10.1002/jlb.53.5.591

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  10 in total

1.  Effects of submaximal cycling and long-term endurance training on neutrophil phagocytic activity in middle aged men.

Authors:  A K Blannin; L J Chatwin; R Cave; M Gleeson
Journal:  Br J Sports Med       Date:  1996-06       Impact factor: 13.800

2.  Exercise and the neutrophil oxidative burst: biological and experimental variability.

Authors:  D B Pyne; M S Baker; J A Smith; R D Telford; M J Weidemann
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

3.  Granulocyte chemiluminescence response to serum opsonized zymosan particles ex vivo during long-term strenuous exercise, energy and sleep deprivation in humans.

Authors:  P Wiik; P K Opstad; A Bøyum
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

Review 4.  Adhesion molecules, catecholamines and leucocyte redistribution during and following exercise.

Authors:  Roy J Shephard
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

5.  Delayed muscle soreness. The inflammatory response to muscle injury and its clinical implications.

Authors:  D L MacIntyre; W D Reid; D C McKenzie
Journal:  Sports Med       Date:  1995-07       Impact factor: 11.136

Review 6.  Flow cytometry. Principles and applications in exercise immunology.

Authors:  H Gabriel; W Kindermann
Journal:  Sports Med       Date:  1995-11       Impact factor: 11.136

Review 7.  Respiratory muscle injury in animal models and humans.

Authors:  W D Reid; N A MacGowan
Journal:  Mol Cell Biochem       Date:  1998-02       Impact factor: 3.396

Review 8.  Regulation of neutrophil function during exercise.

Authors:  D B Pyne
Journal:  Sports Med       Date:  1994-04       Impact factor: 11.136

9.  Lactoferrin in Gingival Crevicular Fluid and Peripheral Blood during Experimental Gingivitis.

Authors:  Burcu Ozdemir; Gonen Ozcan; Burcu Karaduman; Asli Idil Teoman; Eylem Ayhan; Nazmi Ozer; Durdal Us
Journal:  Eur J Dent       Date:  2009-01

10.  Effects of Isokinetic versus Isotonic Training and its Cessation on Total Leukocytes and Lymphocytes Count in Adolescent State-level Weightlifters.

Authors:  Shazlin Shaharudin; Mohamad Faiz Abdul Rahim; Ayu Suzailiana Muhamad
Journal:  Int J Prev Med       Date:  2018-10-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.